Summary
Samenvatting endocrinologie
- Course
- Institution
Samenvatting endocrinologie uit Problemen van Digestief stelsel, endocrien stelsel en voeding met toevoeging van notities uit de les
[Show more]
Seller
Follow
StudentinUZGent
Reviews received
Content preview
InhoudDeel 3: Endocrinologie ............................................................................................................................ 4
Hoofdstuk 1: Diabetes mellitus ........................................................................................................... 4
1.1 Definitie en classificatie ............................................................................................................. 4
1.2 Pathofysiologie .......................................................................................................................... 5
1.3 Type 1 Diabetes Mellitus ........................................................................................................... 6
1.4 Type 2 Diabetes Mellitus ......................................................................................................... 10
1.5 Klinisch onderzoek ................................................................................................................... 13
1.6 Diagnostiek .............................................................................................................................. 14
1.7 Behandeling van DM ............................................................................................................... 15
1.8 Follow – up van diabetestherapie ........................................................................................... 32
1.9 Chronische verwikkelingen van DM ........................................................................................ 33
1.10 Enkele specifieke problemen ................................................................................................. 38
Hoofdstuk 2: Hypoglycemie............................................................................................................... 45
2.1 Oorzaken.................................................................................................................................. 45
2.2 Insulinoom ............................................................................................................................... 45
Hoofdstuk 3: Hypofyse ...................................................................................................................... 47
3.1 Basisbegrippen ........................................................................................................................ 47
3.2 Indeling hypofyseadenomen ................................................................................................... 48
3.3 Kliniek hypofyse ....................................................................................................................... 50
3.4 Hypofysestimulatietesten ........................................................................................................ 57
Hoofdstuk 4: Hypogonadisme en gynaecomastie ............................................................................. 59
4.1 Mannelijk endocrien hypogonadisme ..................................................................................... 59
4.2 Gynaecomastie ........................................................................................................................ 64
4.3 Turner syndroom, endocrinologische aandachtspunten op volwassen leeftijd ...................... 65
Hoofdstuk 5: Bijniercortex ................................................................................................................ 67
5.1 Investigatie van bijniercortexfunctie ....................................................................................... 67
5.2 Ziekten van de bijniercortex .................................................................................................... 69
5.3 Corticotherapie ........................................................................................................................ 77
Hoofdstuk 6: Bijniermerg................................................................................................................... 80
6.1 Investigatie van bijniermergfunctie ......................................................................................... 80
6.2 Ziekten van het bijniermerg .................................................................................................... 80
Hoofdstuk 7: Neuro – endocriene tumoren ...................................................................................... 83
7.1 Histopathologie en classificatie ............................................................................................... 83
7.2 Pathofysiologie en kliniek ........................................................................................................ 83
1
, 7.3 Carcinoïd – syndroom .............................................................................................................. 83
7.4 Diagnose .................................................................................................................................. 84
7.5 Therapie ................................................................................................................................... 84
Hoofdstuk 8: Hirsutisme .................................................................................................................... 85
8.1 Definitie ................................................................................................................................... 85
8.2 Etiologie ................................................................................................................................... 85
8.3 Differentiaaldiagnose............................................................................................................... 85
8.4 Therapie ................................................................................................................................... 85
8.5 Organisch hirsutisme ............................................................................................................... 86
Hoofdstuk 9: Variaties van de seksuele ontwikkeling en genderdysforie.......................................... 87
9.1 Indeling .................................................................................................................................... 87
9.2 Transgenderzorg ...................................................................................................................... 87
Hoofdstuk 10: De schildklier .............................................................................................................. 88
10.1 Basisbegrippen ...................................................................................................................... 88
10.2 Diagnostische exploratie bij schildklierlijden ........................................................................ 90
10.3 Thyrotoxicose ........................................................................................................................ 94
10.4 Hypothyroïdie ...................................................................................................................... 101
10.5 Thyroiditis ............................................................................................................................ 105
10.6 Endemisch en sporadisch niet – toxisch struma.................................................................. 106
10.7 Schildkliertumoren, in bijzonder solitaire thyroïdnodule .................................................... 107
10.8 Het ‘eutyroid sick’ – syndroom ............................................................................................ 113
Hoofdstuk 11: Dyslipidemie............................................................................................................. 114
11.1 Inleiding ............................................................................................................................... 114
11.2 Metabolisme........................................................................................................................ 115
11.3 Concentraties in plasma ...................................................................................................... 116
11.4 Kliniek .................................................................................................................................. 116
11.5 Gevolgen van dyslipidemie .................................................................................................. 119
11.6 Aanpak en behandeling ....................................................................................................... 120
11.7 Medicatie ............................................................................................................................. 122
Hoofdstuk 12: Obesitas ................................................................................................................... 125
12.1 Inleiding ............................................................................................................................... 125
12.2 Definitie obesitas ................................................................................................................. 125
12.3 Etiologie en fysiologie .......................................................................................................... 126
12.4 Endocriene aspecten van obesitas ...................................................................................... 127
12.5 Functies van vetweefsel ...................................................................................................... 129
12.6 Vetverdeling......................................................................................................................... 129
2
, 12.7 Somatische gevolgen obesitas ............................................................................................. 130
12.8 Diagnose .............................................................................................................................. 130
12.9 Therapie ............................................................................................................................... 130
Hoofdstuk 13: Aandoeningen van de bijschildklieren en metabole botziekten.............................. 136
13.1 Calcium en fosforhuishouden – basisbegrippen ................................................................. 136
13.2 Aandoeningen van de bijschildklieren................................................................................. 138
13.3 Metabole botaandoeningen ................................................................................................ 143
Hoofdstuk 14: Schildklier en bijschildklierchirurgie ........................................................................ 148
14.1 Chirurgie is anatomie (en embryologie) .............................................................................. 148
14.2 Potentiële complicaties ....................................................................................................... 149
14.3 De schildklierchirurgie ......................................................................................................... 150
14.4 Bijschildklierchirurgie .......................................................................................................... 152
Hoofdstuk 15: Voeding bij obesitas en diabetes ............................................................................. 155
15.1 Basisconcepten .................................................................................................................... 155
15.2 Voedingsaanbevelingen ....................................................................................................... 156
15.3 Voedingsinterventie bij obesitas en DMT2 .......................................................................... 158
15.4 DMT2 ................................................................................................................................... 160
15.5 DMT1 ................................................................................................................................... 161
3
, Deel 3: Endocrinologie
Hoofdstuk 1: Diabetes mellitus
1.1 Definitie en classificatie
• = chronische stoornis in metabolisme koolhydraten, vetten en eiwitten
o Tekort aan insuline: afbraak eiwitten en vrijstelling van VVZ
• Verhoogde bloedglucosespiegel (hyperglycemie), al dan niet met glucosurie
• Veroorzaakt door
o Absoluut insuline tekort (DMT1)
o Relatief insuline tekort (DMT2), al dan niet met insulineresistentie
• Zeer frequent, met wereldwijde sterke toename in prevalentie (8.5% in België, velen die het
nog niet weten)
o Wereldwijd: 537 miljoen mensen tss 20 – 79 jaar
o → zorgt voor grote kosten op bevolkingsniveau
o Veel levendgeborenen bloodgesteld aan hyperglycemie tijdens ZS bij moeder
o 1/5 > 65j: DM (vooral DMT2)
o Nog zeer veel mensen zijn ongediagnosticeerd → nog veel mogelijk preventief
• Acute levensbedreigende situaties mogelijk door insulinegebrek
o Diabetische ketoacidose (DMT1)
o Hyperosmolair hyperglycemisch coma (DMT2)
• Op lange termijn onherstelbare schade aan ogen, nieren , zenuwen
o Diabetes: belangrijkste oorzaak van verworven blindheid en nierdialyse in westerse
wereld
• Sterk verhoogd risico op hart – en vaatziekten
• Glucosehomeostase → vitaal voor energievoorziening van alle weefsel: indeling
o Gestoorde glycemie
o Gestoorde glucosetolerantie (impaired glucose tolerance, IGT)
▪ Nuchtere glucose normaal, maar lichaam reageert niet adequaat op
glucosechallange test: 2u na glucosebelasting tussen 140 en 200 mg/dl
▪ ↑ Risico op ontwikkeling DM
▪ Vaak typisch risicoprofiel (hypertensie, obesitas, hyperlipidemie = metabool
syndroom) → risico op ontwikkeling DM en cardiovasculaire ziekte
o Verhoogde nuchtere glycemie (impaired fasted glucose)
▪ Verhoogde nuchtere glucose > 100 mg/dl maar < 126 mg/dl
o DM (volgens ADA criteria)
• Klinische vormen
o DMT1: βcel destructie = absolute insulinedeficiëntie (immuun – gemedieerd)
o DMT2: insulineresistentie (relatief tekort), variabele insulinesecretie
o Zwangerschapsdiabetes (gestational diabetes)
▪ Prevalentie: 9.5% in België
▪ Verdwijnt (tijdelijk) na bevalling, verhoogd risico op DMT2 (30 – 50%)
o Andere specifieke vormen van DM
▪ Zeer uiteenlopende etiologieën
▪ Monogenetische vormen: MODY (Maturity Diabetes of the Young)
• AR, 1 gen
4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller StudentinUZGent. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $12.27. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
79373 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now